English
Home > Products > 8007-04-3

China 8007-04-3 Factory

We now have a skilled, performance team to supply good quality services for our consumer. We often follow the tenet of customer-oriented, details-focused for 8007-04-3,CAS NO 8007-04-3,HUMULUS LUPULUS (HOPS) CONE OIL, Our solutions are widely recognized and reliable by users and can satisfy continuously acquiring economic and social needs.
8007-04-3, At existing our sales network is growing continually, improving service quality to meet customer's demand. If you are interested in any goods , be sure to contact us at anytime. We have been looking forward to forming successful business relationships with you in near future.

Related Products

Hot Products

  • Ertapenem Side Chain

    Ertapenem Side Chain

    Product Name:Ertapenem Side Chain
    CAS No:202467-69-4
    Manufacture site:Ruyu
    Spec:In-house
    Batch size:200kg
    Annual capacity:50mt
  • Torasemide

    Torasemide

    Product Name:Torasemide
    Molecular Formula:C16H20N4O3S
    Molecular Weight;348.42
    CAS Registry Number;56211-40-6
  • 11-a-Hydroxy canrenone methyl ester

    11-a-Hydroxy canrenone methyl ester

    Product Name:11-a-Hydroxy canrenone methyl ester
    Molecular Formula:C24H32O6
    Molecular Weight:416.51
    CAS Registry Number:192704-56-6
  • 5-Bromo-1,2,3-trifluorobenzene

    5-Bromo-1,2,3-trifluorobenzene

    Product Name:5-Bromo-1,2,3-trifluorobenzene
    Molecular Formula:C6H2BrF3
    Molecular Weight:210.98
    CAS Registry Number:138526-69-9
  • Calcobutrol

    Calcobutrol

    Product Name:Calcobutrol
    Molecular Formula:C18H36CaN4O9
    Molecular Weight:492.58
    CAS Registry Number:151878-23-8
  • Z-LYS(Z)-OH

    Z-LYS(Z)-OH

    Product Name:Z-LYS(Z)-OH
    Molecular Formula:C22H26N2O6
    Molecular Weight:414.45
    CAS Registry Number:405-39-0
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

Related Search

CAS NO 8007-04-3

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept